Caitlin B. Conboy

Also affiliated with Mayo Clinic in Arizona

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Tissue-specific transcriptional regulation has diverged significantly between human and mouse”.

Tissue-specific transcriptional regulation has diverged significantly between human and mouse

Nature Genetics(2007)10.1038/ng2047

N/A

0.940DataRank · unranked

526 citations

Robin D. Dowell, Elizabeth S Jacobsen, William Gordon, Timothy W. Danford, Kenzie D. Macisaac +7 more

Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma

Annals of Surgical Oncology(2025)10.1245/s10434-025-18046-6

N/A

0.447DataRank · unranked

11 citations

Vanja Podrascanin, Zhihao Li, Jonas Santol, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more

Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis

Annals of Surgical Oncology(2025)10.1245/s10434-025-17991-6

N/A

0.241DataRank · unranked

4 citations

Jonas Santol, Vanja Podrascanin, Zhihao Li, Markus Ammann, Lionel A. Kankeu Fonkoua +7 more

The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes

Cellular Oncology(2025)10.1007/s13402-025-01133-x

N/A

0DataRank · unranked

0 citations

Jayla T. Millender, Chantal E. McCabe, Ryan D. Watkins, Jennifer A. Yonkus, EeeLN H. Buckarma +7 more

YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape

FEBS Open Bio(2024)10.1002/2211-5463.13901

N/A

0DataRank · unranked

5 citations

Ryan Watkins, Jennifer L. Tomlinson, Jennifer A. Yonkus, Amro M. Abdelrahman, Caitlin B. Conboy +9 more

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Journal of Clinical Investigation(2020)10.1172/jci137110

N/A

0DataRank · unranked

399 citations

Jingchun Yang, EeeLN H. Buckarma, Juan Wang, Yuanhang Liu, Caitlin B. Conboy +9 more

Preclinical evaluation of LCK as a novel therapeutic target in YAP-activated and FGFR2-altered cholangiocarcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.463

N/A

0DataRank · unranked

1 citations

Jennifer A. Yonkus, EeeLN H. Buckarma, Dong‐Gi Mun, Nathan W. Werneburg, Ryan Watkins +13 more